368 related articles for article (PubMed ID: 26526106)
1. Making a Hematopoietic Stem Cell.
Daniel MG; Pereira CF; Lemischka IR; Moore KA
Trends Cell Biol; 2016 Mar; 26(3):202-214. PubMed ID: 26526106
[TBL] [Abstract][Full Text] [Related]
2. Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming.
Izawa K; Yamazaki S; Becker HJ; Bhadury J; Kakegawa T; Sakaguchi M; Tojo A
Exp Hematol; 2020 Sep; 89():68-79.e7. PubMed ID: 32795499
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming mechanisms influence the maturation of hematopoietic progenitors from human pluripotent stem cells.
Heo HR; Song H; Kim HR; Lee JE; Chung YG; Kim WJ; Yang SR; Kim KS; Chun T; Lee DR; Hong SH
Cell Death Dis; 2018 Oct; 9(11):1090. PubMed ID: 30356076
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of hematopoietic stem cells for regenerative medicine.
Nakajima-Takagi Y; Osawa M; Iwama A
Anat Rec (Hoboken); 2014 Jan; 297(1):111-20. PubMed ID: 24293004
[TBL] [Abstract][Full Text] [Related]
5. In vitro generation of HSC-like cells from murine ESCs/iPSCs by enforced expression of LIM-homeobox transcription factor Lhx2.
Kitajima K; Minehata K; Sakimura K; Nakano T; Hara T
Blood; 2011 Apr; 117(14):3748-58. PubMed ID: 21343610
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide gene expression analyses reveal unique cellular characteristics related to the amenability of HPC/HSCs into high-quality induced pluripotent stem cells.
Gao S; Tao L; Hou X; Xu Z; Liu W; Zhao K; Guo M; Wang H; Cai T; Tian J; Gao S; Chang G
Stem Cell Res Ther; 2016 Mar; 7():40. PubMed ID: 26979597
[TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
[TBL] [Abstract][Full Text] [Related]
8. Generation of Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells.
Oguro H
Methods Mol Biol; 2019; 2048():245-257. PubMed ID: 31396942
[TBL] [Abstract][Full Text] [Related]
9. Converting cell fates: generating hematopoietic stem cells de novo via transcription factor reprogramming.
Daniel MG; Lemischka IR; Moore K
Ann N Y Acad Sci; 2016 Apr; 1370(1):24-35. PubMed ID: 26748878
[TBL] [Abstract][Full Text] [Related]
10. Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells.
Batta K; Florkowska M; Kouskoff V; Lacaud G
Cell Rep; 2014 Dec; 9(5):1871-1884. PubMed ID: 25466247
[TBL] [Abstract][Full Text] [Related]
11. Generating autologous hematopoietic cells from human-induced pluripotent stem cells through ectopic expression of transcription factors.
Hwang Y; Broxmeyer HE; Lee MR
Curr Opin Hematol; 2017 Jul; 24(4):283-288. PubMed ID: 28383341
[TBL] [Abstract][Full Text] [Related]
12. Development of patient-specific hematopoietic stem and progenitor cell grafts from pluripotent stem cells, in vitro.
Klump H; Teichweyde N; Meyer C; Horn PA
Curr Mol Med; 2013 Jun; 13(5):815-20. PubMed ID: 23642062
[TBL] [Abstract][Full Text] [Related]
13. Inability of human induced pluripotent stem cell-hematopoietic derivatives to downregulate microRNAs in vivo reveals a block in xenograft hematopoietic regeneration.
Risueño RM; Sachlos E; Lee JH; Lee JB; Hong SH; Szabo E; Bhatia M
Stem Cells; 2012 Feb; 30(2):131-9. PubMed ID: 22131151
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of human induced pluripotent stem cells into erythroid cells.
Ebrahimi M; Forouzesh M; Raoufi S; Ramazii M; Ghaedrahmati F; Farzaneh M
Stem Cell Res Ther; 2020 Nov; 11(1):483. PubMed ID: 33198819
[TBL] [Abstract][Full Text] [Related]
15. The RUNX1 +24 enhancer and P1 promoter identify a unique subpopulation of hematopoietic progenitor cells derived from human pluripotent stem cells.
Ferrell PI; Xi J; Ma C; Adlakha M; Kaufman DS
Stem Cells; 2015 Apr; 33(4):1130-41. PubMed ID: 25546363
[TBL] [Abstract][Full Text] [Related]
16. Vascular niche promotes hematopoietic multipotent progenitor formation from pluripotent stem cells.
Gori JL; Butler JM; Chan YY; Chandrasekaran D; Poulos MG; Ginsberg M; Nolan DJ; Elemento O; Wood BL; Adair JE; Rafii S; Kiem HP
J Clin Invest; 2015 Mar; 125(3):1243-54. PubMed ID: 25664855
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Generation of Engraftable Murine Hematopoietic Stem Cells by Gfi1b, c-Fos, and Gata2 Overexpression within Teratoma.
Tsukada M; Ota Y; Wilkinson AC; Becker HJ; Osato M; Nakauchi H; Yamazaki S
Stem Cell Reports; 2017 Oct; 9(4):1024-1033. PubMed ID: 28943250
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic differentiation of embryonic stem cells.
Orlovskaya I; Schraufstatter I; Loring J; Khaldoyanidi S
Methods; 2008 Jun; 45(2):159-67. PubMed ID: 18593612
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor-mediated reprogramming toward hematopoietic stem cells.
Ebina W; Rossi DJ
EMBO J; 2015 Mar; 34(6):694-709. PubMed ID: 25712209
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives.
Demirci S; Leonard A; Tisdale JF
Stem Cells Transl Med; 2020 Dec; 9(12):1549-1557. PubMed ID: 32725882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
